top of page

mmu_circGigyf2_2018

Basic information of circular RNA
PanCircBase ID:

mmu_circGigyf2_2018

mm39_Chr. Position ID:

chr1|87344539|87371548|+

Gene name:

Gigyf2

Transcript:

ENSMUST00000027475.15

CircRNA type:

Exonic circular (circ)RNA

Exon/Intron count:

13

Exon/intron indexes:

15,16,17,18,19,20,21,22,23,24,25,26,27

Exon/intron offsets:

0,2270,3467,4673,6363,8247,11752,16862,19951,23570,23899,25193,26827

Genomic length:

27009

Exon/intron sizes in nt:

1,67,92,10,81,01,10,11,00,00,00,00,00,00,00,00,00,00,000

Flanking exon/introns:

chr1:87339589-87344539|chr1:87371548-87374033

Splice length:

2018

Other database IDs:

Human Ortholog IDs:
Mature spliced Sequence:

GTCCCTTTAACAATCAGGAGATGGCCGAGTGGTTTCAGGCGGGCTATTTTACTATGTCTTTGCTGGTGAAGAGAGCATGTGATGAAAGCTTCCAGCCCCTTGGTGATATCATGAAAATGTGGGGAAGGGTTCCTTTCTCTCCAGGCCCAGCTCCCCCTCCTCATATGGGAGAATTGGACCAGGAACGCCTGACCAGACAGCAGGAACTCACTGCCTTATACCAGATGCAGCACCTCCAGTACCAGCAGTTCTTAATCCAACAACAGTATGCACAGGTTTTGGCTCAACAGCAGAAAGCAGCTTTGTCATCTCAGCAGCAACAACAATTGGCTCTTCTTCTGCAGCAGTTCCAGGCTCTGAAGATGAGAATGTCTGATCAGAACATCATTCCCTCAGTAACTAGGTCTGTGTCAGTGCCAGATACTGGCTCTATCTGGGAGCTTCAGCCAGCAGCCTCACAGCCTGCAGTTTGGGAAGGTGGTAGTGTATGGGATCTTCCCCTGGACACCACAGCACCAGGTCCTTCCCTGGAACAGCTTCAGCAGCTAGAGAAGGCCAAAGCTGCAAAGTTAGAACAGGAGAGAAGAGAGGCAGAAATGAGGGCAAAAAGGGAAGAGGAGGAGCGAAAGAGGCAAGAAGAACTCCGAAGACAACAGGAGGAAATCCTTCGGAGGCAGCAGGAGGAAGAAAGGAAAAGACGGGAAGAAGAGGAACTTGCTCGAAGGAAGCAGGAGGAGGCTCTGCGGCGCCAACGGGAGCAAGAGATTGCGCTAAGGCGGCAGCGAGAAGAGGAGGAAAGACAGCAGCAGGAAGAAGCTCTTAGACGATTGGAGGAGCGGAGGAGAGAAGAGGAGGAAAGGCGGAAGCAGGAAGAACTGCTGCGCAAGCAGGAAGAGGAGGCTGCCAAATGGGCCCGGGAAGAGGAAGAAGCCCAGCGCCGACTGGAAGAGAACCGGCTGCGCATGGAGGAGGAGGCTGCCAGACTTCGGCATGAAGAAGAAGAAAGAAAACGGAAGGAATTGGAGCTGCAGAGGCAGAAGGATCTGATGCGTCAGAGACAGCAGCAGCAAGAGGCTCTCCGAAGGCTGCAGCAGCAACAGCAGCAGCAACAGCTTGCACAAATGAAGCTTCCCTCTTCGTCAACGTGGGGTCAGCAGTCTAACACAGCAACATGTCAGTCCCAGGCCACGCTGTCATTGGCTGAGATCCAGAAGCTGGAAGAAGAACGAGAACGCCAGCTTCGTGAAGAGCAAAGACGTCAGCAGAGGGAATTGATGAAAGCTCTCCAGCAGCAGCAGCAGCAGCAGCAACAACAAAAACTCTCAGGTTGGGGGAATGTCAGCAAACCTGCAGGTACCACCAAGTCTCTACTAGAGATCCAGCAGGAAGAGGCCAGGCAGATGCAGAAGCAGCAGCAGCAGCAACAACAACAACAACAGCAACACCAGCAATCAAACAGAGCCCGGAACAGCACACATTCCAACCTGCATACCAGCCTTGGGAATTCTGTATGGGGCTCTATAAACACAGGTCCTTCTAACCAGTGGGCGTCTGAGCTAGTCAGTAGTATCTGGAGTAATGCAGACACCAAAAACTCCAACATGGGGTTTTGGGATGATGCAGTGAAAGAGGTGGGACCTAGAAATTCAACAAATAAAAATAAAAACAACGCCAGTCTCAGTAAATCTGTAGGTGTGTCTAACCGGCAGAATAAGAAAGTAGAAGAAGAAGAAAAGTTGCTGAAGCTCTTTCAGGGAGTAAATAAAGCCCAAGATGGATTTACCCAGTGGTGTGAACAGATGCTTCATGCCCTTAATACGGCAAATAACTTGGATGTTCCCACGTTTGTTTCTTTCTTGAAAGAAGTGGAGTCTCCTTATGAAGTCCATGACTATACCAGGGCCTATTTAGGAGATACTTCCGAGGCCAAGGAGTTTGCCAAGCAGTTCCTTGAACGCCGTGCCAAACAGAAAGTCAACCAGCAGCGTCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG

Divergent primers for circular RNA PCR

Primer Set-1

Forward primer
Tm
Reverse primer
Tm
Product size

TTCCGAGGCCAAGGAGTTTG

60.25

AAATAGCCCGCCTGAAACCA

59.96

149

Primer Set-2

Forward primer
Tm
Reverse primer
Tm
Product size

CCAAGGAGTTTGCCAAGCAG

59.68

AAATAGCCCGCCTGAAACCA

59.96

141

PCR template sequence:

TTCCGAGGCCAAGGAGTTTGCCAAGCAGTTCCTTGAACGCCGTGCCAAACAGAAAGTCAACCAGCAGCGTCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGGTCCCTTTAACAATCAGGAGATGGCCGAGTGGTTTCAGGCGGGCTATTTTACTATGTCTTTGCTGGTGAAGAGAGCATGTGATGAAAGCTTCCAGCCCCT

Note: Users can design additional primers for provided template sequence using Primer3 or NCBI primer-blast.
miRNAs associated with circular RNAs
No of miRNAs

14

Interacting miRNAs (#binding sites)

mmu-miR-127-5p(2), mmu-miR-9-5p(1), mmu-miR-34c-5p(1), mmu-miR-34a-5p(1), mmu-miR-211-5p(1), mmu-miR-204-5p(1), mmu-miR-217-5p(1), mmu-miR-138-5p(1), mmu-miR-185-5p(1), mmu-miR-495-3p(1), mmu-miR-136-5p(1), mmu-miR-34b-5p(1), mmu-miR-335-3p(1), mmu-miR-1904(1)

siRNAs for circular RNA silencing
Junction sequence

GCAGCAGCAGCAGGTCCCTTTAACAA

siRNA sets

TTAAAGGGACCTGCTGCTG, TAAAGGGACCTGCTGCTGC, AAAGGGACCTGCTGCTGCT

Protein-coding potential of circular RNAs

CPAT analysis

CPAT ORF ID
CPAT Fickett
CPAT Hexamer
Coding probabilty
ORF length

CIRCGIGYF2_2018_ORF_1

1.0431

0.288685265

0.999996945

2067

ORF sequence:

ATGGCCGAGTGGTTTCAGGCGGGCTATTTTACTATGTCTTTGCTGGTGAAGAGAGCATGTGATGAAAGCTTCCAGCCCCTTGGTGATATCATGAAAATGTGGGGAAGGGTTCCTTTCTCTCCAGGCCCAGCTCCCCCTCCTCATATGGGAGAATTGGACCAGGAACGCCTGACCAGACAGCAGGAACTCACTGCCTTATACCAGATGCAGCACCTCCAGTACCAGCAGTTCTTAATCCAACAACAGTATGCACAGGTTTTGGCTCAACAGCAGAAAGCAGCTTTGTCATCTCAGCAGCAACAACAATTGGCTCTTCTTCTGCAGCAGTTCCAGGCTCTGAAGATGAGAATGTCTGATCAGAACATCATTCCCTCAGTAACTAGGTCTGTGTCAGTGCCAGATACTGGCTCTATCTGGGAGCTTCAGCCAGCAGCCTCACAGCCTGCAGTTTGGGAAGGTGGTAGTGTATGGGATCTTCCCCTGGACACCACAGCACCAGGTCCTTCCCTGGAACAGCTTCAGCAGCTAGAGAAGGCCAAAGCTGCAAAGTTAGAACAGGAGAGAAGAGAGGCAGAAATGAGGGCAAAAAGGGAAGAGGAGGAGCGAAAGAGGCAAGAAGAACTCCGAAGACAACAGGAGGAAATCCTTCGGAGGCAGCAGGAGGAAGAAAGGAAAAGACGGGAAGAAGAGGAACTTGCTCGAAGGAAGCAGGAGGAGGCTCTGCGGCGCCAACGGGAGCAAGAGATTGCGCTAAGGCGGCAGCGAGAAGAGGAGGAAAGACAGCAGCAGGAAGAAGCTCTTAGACGATTGGAGGAGCGGAGGAGAGAAGAGGAGGAAAGGCGGAAGCAGGAAGAACTGCTGCGCAAGCAGGAAGAGGAGGCTGCCAAATGGGCCCGGGAAGAGGAAGAAGCCCAGCGCCGACTGGAAGAGAACCGGCTGCGCATGGAGGAGGAGGCTGCCAGACTTCGGCATGAAGAAGAAGAAAGAAAACGGAAGGAATTGGAGCTGCAGAGGCAGAAGGATCTGATGCGTCAGAGACAGCAGCAGCAAGAGGCTCTCCGAAGGCTGCAGCAGCAACAGCAGCAGCAACAGCTTGCACAAATGAAGCTTCCCTCTTCGTCAACGTGGGGTCAGCAGTCTAACACAGCAACATGTCAGTCCCAGGCCACGCTGTCATTGGCTGAGATCCAGAAGCTGGAAGAAGAACGAGAACGCCAGCTTCGTGAAGAGCAAAGACGTCAGCAGAGGGAATTGATGAAAGCTCTCCAGCAGCAGCAGCAGCAGCAGCAACAACAAAAACTCTCAGGTTGGGGGAATGTCAGCAAACCTGCAGGTACCACCAAGTCTCTACTAGAGATCCAGCAGGAAGAGGCCAGGCAGATGCAGAAGCAGCAGCAGCAGCAACAACAACAACAACAGCAACACCAGCAATCAAACAGAGCCCGGAACAGCACACATTCCAACCTGCATACCAGCCTTGGGAATTCTGTATGGGGCTCTATAAACACAGGTCCTTCTAACCAGTGGGCGTCTGAGCTAGTCAGTAGTATCTGGAGTAATGCAGACACCAAAAACTCCAACATGGGGTTTTGGGATGATGCAGTGAAAGAGGTGGGACCTAGAAATTCAACAAATAAAAATAAAAACAACGCCAGTCTCAGTAAATCTGTAGGTGTGTCTAACCGGCAGAATAAGAAAGTAGAAGAAGAAGAAAAGTTGCTGAAGCTCTTTCAGGGAGTAAATAAAGCCCAAGATGGATTTACCCAGTGGTGTGAACAGATGCTTCATGCCCTTAATACGGCAAATAACTTGGATGTTCCCACGTTTGTTTCTTTCTTGAAAGAAGTGGAGTCTCCTTATGAAGTCCATGACTATACCAGGGCCTATTTAGGAGATACTTCCGAGGCCAAGGAGTTTGCCAAGCAGTTCCTTGAACGCCGTGCCAAACAGAAAGTCAACCAGCAGCGTCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGGTCCCTTTAACAATCAGGAGATGGCCGAGTGGTTTCAGGCGGGCTATTTTACTATGTCTTTGCTGGTGA

Peptide sequence:

MAEWFQAGYFTMSLLVKRACDESFQPLGDIMKMWGRVPFSPGPAPPPHMGELDQERLTRQQELTALYQMQHLQYQQFLIQQQYAQVLAQQQKAALSSQQQQQLALLLQQFQALKMRMSDQNIIPSVTRSVSVPDTGSIWELQPAASQPAVWEGGSVWDLPLDTTAPGPSLEQLQQLEKAKAAKLEQERREAEMRAKREEEERKRQEELRRQQEEILRRQQEEERKRREEEELARRKQEEALRRQREQEIALRRQREEEERQQQEEALRRLEERRREEEERRKQEELLRKQEEEAAKWAREEEEAQRRLEENRLRMEEEAARLRHEEEERKRKELELQRQKDLMRQRQQQQEALRRLQQQQQQQQLAQMKLPSSSTWGQQSNTATCQSQATLSLAEIQKLEEERERQLREEQRRQQRELMKALQQQQQQQQQQKLSGWGNVSKPAGTTKSLLEIQQEEARQMQKQQQQQQQQQQQHQQSNRARNSTHSNLHTSLGNSVWGSINTGPSNQWASELVSSIWSNADTKNSNMGFWDDAVKEVGPRNSTNKNKNNASLSKSVGVSNRQNKKVEEEEKLLKLFQGVNKAQDGFTQWCEQMLHALNTANNLDVPTFVSFLKEVESPYEVHDYTRAYLGDTSEAKEFAKQFLERRAKQKVNQQRQQQQQQQQQQVPLTIRRWPSGFRRAILLCLCW

IRESfinder result

IRESfinder score

0.381041423

IRES/non IRES

non-IRES

riboCIRC information

riboCIRC ID

NA

NA

Evidence
Peptide sequence:

NA

logo.png

Institute of Life sciences, Bhubaneswar, India

bottom of page